Miso Clinic · Clinical column

Skin Boosters in Daegu: Where to Start — a Map Drawn from Five Concerns

Skin booster names multiply every year. Rejuran, Rituo, CellREDM, Gouri, Juvelook, Byryzn, Radiesse, Hilowave — that's eight just counting those covered here. Start comparing names one by one and there's no end. This article starts from the other direction. It divides what has changed in the mirror into five concerns, and links like a map which types are candidates for each and where the more detailed articles are. There's no ranking.

Clinical column About 7 min October 2026 Miso Clinic, Daegu · Dr. Lee Chi-Hak, Medical Director

The short answer

Choosing a skin booster starts not from a product name but from “what has decreased right now.” Depending on whether hydration · texture has roughened, skin has thinned and lost elasticity, fine lines have settled, volume has hollowed, or the eye area is the concern, the candidate types (hyaluronic acid · PN · hADM · liquid PCL · PDLLA · CaHA) differ. Trials comparing these types side by side in the same people are rare, so it's more accurate to choose by “what it targets” and “whether it can be reversed” than by which is better. Miso Clinic in Daegu (4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, +82-53-428-2700) has boosters including these eight, and after first sorting the concern, we tell you plainly when a type doesn't fit (clinical judgement).

What do you choose a skin booster by?

Changes with age fall into two broad kinds: volume hollowing (fat · bone) and the skin itself thinning (dermal collagen). Most skin boosters target the latter, the dermis. So if you try to fill hollowed volume with a booster alone, expectation and result diverge.

At consultation Miso Clinic first sorts the concern into the five below, then narrows down in the order type → formulation → product (clinical judgement).

Five concerns and the type to look at first
ConcernType to look at firstMiso Clinic options
Hydration · textureHyaluronic acid · PNHilowave · Byryzn · Rejuran
Thinness · elasticityhADM · liquid PCL · PNRituo · CellREDM · Gouri · Rejuran
Fine linesCross-linked hyaluronic acid · liquid PCL · PDLLAByryzn · Gouri · Juvelook Skin
Hollowing · volumeCaHA · PDLLA (volume type) · fillerRadiesse (undiluted or diluted) · Juvelook Volume
Eye areaPN · small-particle hADM · hyaluronic acidRejuran · CellREDM · Byryzn (with care over depth)

A table setting all eight on one page and comparing formulation · target · reversibility is in Skin boosters compared at a glance.

If hydration and texture are the concern, what do you look at first?

The skin feels tight, makeup lifts, and light doesn't reflect evenly. Here the candidates are materials that hold water and materials that change the recovery environment.

  • Hyaluronic acid booster (Hilowave) — a formulation containing both high- and low-molecular-weight hyaluronic acid. Its approved purpose in Korea is “physical restoration,” and I couldn't find any human clinical trial. On the other hand, it can be broken down with hyaluronidase.
  • Byryzn (cross-linked hyaluronic acid) — hyaluronic acid divided and placed shallowly in the dermis. It's also a type that can be dissolved and reversed.
  • Rejuran (PN) — not a filling material but one that changes the dermal environment as it breaks down. In a 27-person split-face trial, improvement rates in roughness · pore volume · hydration measures were higher than on the hyaluronic acid side, but subjective cosmetic scales showed no difference (Lee 2022).

For people having a booster for the first time, Miso Clinic recommends reversible hyaluronic acid or PN, which breaks down, first (clinical judgement). What PN is and how it differs from PDRN is in The difference between PN and PDRN.

If skin has thinned and lost elasticity, which type?

Fine texture is rough, the skin looks see-through, and it feels less thick when pinched. There are three approaches here.

Three approaches for thinned skin
ApproachProductWhat it doesMore
Putting material in directlyRituo · CellREDM (hADM)Places dermal matrix with the cells removed from human skin into the dermisSkin that suits Re2O
Signalling the skin to make itGouri (liquid PCL)Spreads as a sheet along the dermis without particles, stimulating collagen-making pathwaysSkin that suits Gouri
Changing the environmentRejuran (PN)Changes the dermis's recovery environment as it breaks downSkin that suits Rejuran

Rituo has a Yonsei Severance Hospital double-blind randomized split-face trial (20 people · 20 weeks, hyaluronic acid on the other side), but it's exploratory in scale (Severance 2026). CellREDM is in the same hADM line with smaller particles of about 75 μm, and I couldn't confirm any published human trial of the product itself. Gouri's human data for the liquid type remain at case-report scale (2 people · 12 weeks).

I couldn't confirm any trial directly comparing the three approaches in the same people. So rather than “which is better,” it's right to choose by whether you want to lift the whole face evenly, add focused support to thin areas, or need a low-burden start because your skin is sensitive.

If fine lines have settled in, what are the candidates?

Fine lines that remain even without expression are often a sign of a thinned dermis. There are three candidates.

  • Byryzn — there is a human study naming the product. In a 20-person single-arm pilot, the wrinkle scale fell about 40% at 8 weeks and held at about 33% at 12 weeks. It should be read together with the fact that it had no control group (Lee 2024).
  • Gouri — divided across the whole face to address texture and fine lines together. It's an irreversible material, so we start conservatively.
  • Juvelook Skin — a formulation containing PDLLA 25.5 mg and hyaluronic acid 4.5 mg (30 mg per vial). Its target differs from Juvelook Volume (200 mg) of the same name. See The difference between Juvelook Skin and Volume.

Lines that form a single groove, like nasolabial folds, are usually a matter of weight and shadow, not a booster's job. Separate the cause first in Why nasolabial folds deepen.

If the cheeks are hollow, is a skin booster enough?

Usually not. Hollowing is often a problem below the dermis, in the fat layer. In a study measuring 30 cadavers, skin was 2.1 ± 0.4 mm but superficial fat was 5.2 ± 1.9 mm, larger both in thickness and individual variation (Lee 2021). It's hard to make up a fat-layer shortfall with a booster that targets the dermis.

Here are the options Miso Clinic looks at in that case.

  • Radiesse (CaHA) — undiluted, it creates volume immediately; diluted, its character shifts toward texture. The dilution study assigned 1:2 · 1:4 · 1:6 by skin thickness in 20 people on the neck · décolletage, and doesn't compare ratios with each other. More is in Radiesse dilution ratio and injection plane.
  • Juvelook Volume — a formulation with over six times the PDLLA content of Skin (there's also a 50 mg Juvelook in between).
  • Hyaluronic acid filler — when contours need fine adjustment or you need room to reverse.

CaHA has no dissolving agent. So Miso Clinic doesn't use Radiesse in the lips · under the eyes (clinical judgement). The order for cases where hollowing and thinning come together, as in the 40s · 50s, is set out in Skin boosters in your 40s · 50s.

Why is the eye area chosen separately?

The eye area has relatively thin skin on the face and is a place where vessels easily show through. Even the same product needs a different amount and depth around the eyes.

  • Start with the type of dark circles — in a study classifying 65 people, pigmented 5% · vascular 14% · structural 3% · mixed 78% (Huang 2014). Colour problems aren't solved by boosters.
  • PN — there's literature covering the indications · limits of hyaluronic acid filler and PN under the eyes (J Clin Med 2026). It's not a material that fills volume.
  • CellREDM — the smaller-particle option among hADM, so it's relatively easy to divide across thin areas.
  • Byryzn — if placed too shallowly, a bluish Tyndall effect can show through. Under the eyes we place it deeper and in smaller amounts (clinical judgement).

The order for choosing an eye-area booster is written separately in Choosing an eye-area skin booster.

Can it be reversed, and can several be combined?

Eight products by reversibility
ProductCategoryDissolving injection
Byryzn · HilowaveHyaluronic acidYes — hyaluronidase
RejuranPNNone — a material that breaks down
Rituo · CellREDMhADMNone — a material that breaks down
GouriLiquid PCLNone
JuvelookPDLLA + HANo established method found
RadiesseCaHANone — no dissolving agent exists

With irreversible materials, we design to start on the low side and add later. Several types can be used together, but Miso Clinic doesn't layer them on the same day; we put in one first, check the condition at 2–4 weeks, then decide the next (clinical judgement). That's because if a reaction occurs, we need to be able to tell which one caused it. The order and interval are in Combining skin boosters.

Choosing a skin booster in Daegu: frequently asked questions

Which skin booster suits me?

They can't be ranked. Each type targets something different, and trials comparing them side by side are rare. Decide first whether the concern is hydration · texture, thinness · elasticity, fine lines, hollowing · volume, or the eye area, and the candidate types narrow down.

It's my first time — which type should I start with?

Miso Clinic recommends reversible hyaluronic acid (Byryzn · Hilowave) or PN, which breaks down (Rejuran), first. It's not too late to look at irreversible materials once the direction is clear.

My cheeks are hollow — will a skin booster fill them?

Usually not. Hollowing is often a problem of the fat layer below the dermis. We also look at options that deal with volume, such as undiluted Radiesse, Juvelook Volume and hyaluronic acid filler.

Which skin boosters can be dissolved?

Among Miso Clinic's boosters, the hyaluronic acid types Byryzn and Hilowave. Rejuran · Rituo · CellREDM are materials that break down but have no dissolving injection, and Gouri · Radiesse have no dissolving agent either.

Can I have several skin boosters at once?

They can be used together, but we don't layer them on the same day. We put one in first, check the condition after 2–4 weeks, then decide the combination and order.

Where can I get a skin booster consultation in Daegu?

Miso Clinic in Daegu is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82-53-428-2700; weekdays 11:00–19:00 · Saturday 10:00–16:00 (no lunch break); closed Sundays · public holidays.

Clinical columns to read next

Product reference

Miso Clinic booster notes: Rejuran · Rituo · CellREDM · Gouri · Juvelook · Byryzn · Radiesse · Hilowave · all boosters compared

Clinic

This column was written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu. The treatment criteria and injection design are written exactly as we actually use them.

Miso Clinic
Medical DirectorLee Chi-Hak, MD
Address4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu (Exit 1, Kyungpook National University Hospital Station) · tower parking in the building
Phone053-428-2700
KakaoTalk consultationMiso Clinic Daegu channel
KakaoTalk channelAdd the channel
Opening hoursWeekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays
Clinical columnSee all columns
Reference libraryAll booster and lifting device references

References

  1. Eye-area comparison trial of PN and hyaluronic acid — Lee YJ et al., J Dermatolog Treat 2022;33(1):254–260, PMID 32248707. Randomised · double-blind · split face, 27 people, three sessions 2 weeks apart. No difference between sides in subjective cosmetic scales (VAS · GAIS); improvement rates for roughness · pore volume · elasticity · hydration higher on the PN side. No difference in dermal density. (Cited from /column/daegu-rejuran-skin-fit/)
  2. Byryzn human study — Lee JH et al., J Cosmet Dermatol 2024;23(2):409–416, DOI 10.1111/jocd.15944. Prospective · single-centre · single-arm pilot, 20 people (mean age 54.1), 3 intradermal injections 2 weeks apart, observed 12 weeks. Lemperle wrinkle scale 2.60 ± 0.60 → 1.55 ± 0.51 at 8 weeks (about 40% reduction), held at about 33% at 12 weeks. Transient subcutaneous nodule in 1 person. No control group.
  3. Re2O split-face trial — Yonsei University Severance Hospital, split-face double-blind randomised trial (NCT07155278), International Journal of Molecular Sciences 2026. 20 people · 20 weeks · Re2O on one side, hyaluronic acid on the other. Exploratory in scale.
  4. CellREDM product information — made by Hans Biomed (Korean rights Hugel). hADM fine particles about 75 μm (manufacturer’s figure). We found no published human trial of CellREDM itself.
  5. Gouri product information — developed by Dexlevo (Korea). Polycaprolactone (PCL) 21% made into a liquid without microparticles (manufacturer’s disclosure). The commonly quoted 6–12 months is based on the PCL degradation period; we found no data measuring the duration of the liquid form’s effect in people. Does not dissolve with hyaluronidase. (Cited from /gouri/ · /column/pcl-types/)
  6. Human data on liquid PCL — Brito K, Ong D, Annals of Case Reports 2023;8(4):1371 — 2 people, two sessions 4 weeks apart, 12-week follow-up, no control group · biopsy. Byeon H et al., Clin Cosmet Investig Dermatol 2026, DOI 10.2147/CCID.S571602 — 7 cases of bruising lasting months after liquid PCL injection (vessel-rich areas such as infraorbital), all resolved. No human study directly comparing liquid and microsphere forms found. (Cited from /column/pcl-types/)
  7. Juvelook product information — PDLLA microparticles + hyaluronic acid. Juvelook Skin 30 mg (PDLLA 25.5 mg + HA 4.5 mg), Juvelook 50 mg (PDLLA 42.5 mg + HA 7.5 mg), Juvelook Volume 200 mg (PDLLA 170 mg + HA 30 mg) — per the manufacturer's official product page. No established method of reversal confirmed. (Cited from /juvelook/)
  8. Hilowave product information — high- + low-molecular-weight hyaluronic acid, minimal cross-linking, 48 mg hyaluronic acid in 2.0 mL. Korean medical device (biomaterial for tissue repair) class 4; intended use: temporary improvement of facial wrinkles through physical restoration. Can be broken down with hyaluronidase. No human clinical trial found (1 preclinical). (Cited from /hilowave/)
  9. Korean approval of CaHA — Radiesse: MFDS approval 2010; intended use temporary improvement of facial wrinkles · temporary restoration of hand volume (2017); microspheres 25–45 μm · 30% of total weight (Merz). Dclassy: made by CGBio · supplied by DNC Aesthetics; tissue repair material; intended use temporary improvement of facial wrinkles; sizes 0.8 mL · 1.5 mL. I couldn't confirm any published clinical trial of Dclassy itself.
  10. CaHA dilution — 2017 neck · décolletage study, 20 people, 1:2 · 1:4 · 1:6 assigned by skin thickness, type I collagen increased on biopsy at baseline · 4 · 7 months. Not a study comparing ratios with each other.
  11. No dissolving agent for CaHA — Safety of Calcium Hydroxylapatite: A Review (2017); in an analysis of adverse events in 5,081 treatments, nodules were the common one. There's no agent that dissolves CaHA; nodule management is by dispersing or removing. (Cited from /column/daegu-caha-booster/)
  12. Individual variation in facial layer thickness — Lee KW et al., Clinical Anatomy 2021;34(7):1050–1058, PMID 33583088. 3D measurement of 30 fixed cadavers; skin 2.1 ± 0.4 mm, superficial fat 5.2 ± 1.9 mm.
  13. Types of dark circles — Huang YL et al., Int J Dermatol 2014;53(2):164. 65 people classified — pigmented 5% · vascular 14% · structural 3% · mixed 78%.
  14. Under-eye HA and PN — Hyaluronic Acid Fillers Versus Polynucleotides for Under-Eye Rejuvenation, Journal of Clinical Medicine 2026. Literature covering indications and limits for use around the eyes.
  15. Korean medical advertising law — Medical Service Act Article 56(2), which prohibits testimonial advertising, comparison with other medical institutions and superlative claims.
  16. Miso Clinic clinical guidelines — criteria for indications, design by area, pre-treatment explanation and consent. The source of sentences marked “clinical judgement” in this column.

Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.

← Clinical columns · Reference library · Miso Clinic home

한국어 · English · 日本語